Form D · Pharmaceuticals
SANCILIO PHARMACEUTICALS COMPANY, INC.
Riviera Beach, FL · CIK 0001641908
Offering snapshot reported Jan 22, 2018 · SEC filing
- Reported sold
- $5M Offering amount: $5.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $193K Reported outside-investor minimum
- First sale
- Jan 9, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 22, 2018 | Initial | $5,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-303770
Source: Form D, filed Jan 22, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Albert Cavagnaro | Executive |
| John Celentano | Director |
| Jim Gale | Director |
| Geoffrey Glass | Director, Executive |
| Patrick Gray | Director |
| Oscar Groet | Director |
| Dennis Langer | Director |
| Tony Lodovico | Executive |
| Leandra Mollanazar | Executive |
| Frederick Sancilio | Director |
| Thorsteinn Thorsteinsson | Executive |
| Marc Wolff | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2129 N. Congress Avenue
Riviera Beach, FL, 33404
Riviera Beach, FL, 33404